Fierce Biotech1 min read
savePriavoid’s Alzheimer’s pill fails to prove efficacy in phase 2 trial
Priavoid’s pill for Alzheimer's disease has failed to prove its effectiveness in a phase 2 dementia study, although the German biotech pointed to encouraging signs in the longer-term data.
comments(0)
5-min edit window · permanent after that